FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34031911000001108: Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Mar 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
103183201000001110 Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106859601000001119 Ropilynz XL 8mg tablets (Lupin Healthcare (UK) Ltd) 28 tablet 2 x 14 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets Is a Ropinirole 8mg modified-release tablets 28 tablet true Inferred relationship Existential restriction modifier
Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets Has AMP Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) true Inferred relationship Existential restriction modifier
Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Ropinirole hydrochloride true Inferred relationship Existential restriction modifier
Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ropinirole true Inferred relationship Existential restriction modifier
Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ropilynz XL 8mg tablets (Lupin (Europe) Ltd) 28 tablet 2 x 14 tablets Has basis of strength substance Ropinirole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start